Collaboration Key To Chinese Innovation And Global Ambitions – China Healthcare Investment Conference
This article was originally published in PharmAsia News
BGI CEO Jun Wang and Simcere Founder Jisheng Ren share views on collaboration and talent retention in China.
You may also be interested in...
After announcing the intent to form a partnership a year ago, Merck & Co. announced Sept. 13, a collaboration with BGI (formerly the Beijing Genomics Institute) for discovery and development of biomarkers and genomic technologies
Top executives from three high-flying Chinese biotechs, all of which have gone public on Nasdaq and in Hong Kong, offered lessons learned and looked forward to what’s ahead in a panel session at the recent JPM conference.
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?